1. Franz, M, Scholz, M, Henze, I, et al. Detection of colon polyps by a novel, polymer pattern-based full blood test. J Transl Med 2013; 11: 278.
Google Scholar | Crossref | Medline2. Itzkowitz, S, Brand, R, Jandorf, L, et al. A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol 2008; 103: 2862–2870.
Google Scholar | Crossref | Medline | ISI3. Hardcastle, JD, Chamberlain, JO, Robinson, MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472–1477.
Google Scholar | Crossref | Medline | ISI4. Kronborg, O, Fenger, C, Olsen, J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467–1471.
Google Scholar | Crossref | Medline | ISI5. Mandel, JS, Bond, JH, Church, TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365–1371.
Google Scholar | Crossref | Medline | ISI6. Bretthauer, M . Colorectal cancer screening. J Intern Med 2011; 270: 87–98.
Google Scholar | Crossref | Medline | ISI7. Lieberman, DA, Weiss, DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001; 345: 555–560.
Google Scholar | Crossref | Medline | ISI8. Imperiale, TF, Ransohoff, DF, Itzkowitz, SH, et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704–2714.
Google Scholar | Crossref | Medline | ISI9. Duffy, MJ . Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001; 47: 624–630.
Google Scholar | Crossref | Medline | ISI10. Stella Tsai, CS, Chen, HC, Tung, JN, et al. Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer. Am J Pathol 2010; 176: 1619–1628.
Google Scholar | Crossref | Medline11. Tan, E, Gouvas, N, Nicholls, RJ, et al. Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol 2009; 18: 15–24.
Google Scholar | Crossref | Medline | ISI12. Walker, AS, Zwintscher, NP, Johnson, EK, et al. Future directions for monitoring treatment response in colorectal cancer. J Cancer 2014; 5: 44–57.
Google Scholar | Crossref | Medline13. De Maio, G, Rengucci, C, Zoli, W, et al. Circulating and stool nucleic acid analysis for colorectal cancer diagnosis. World J Gastroenterol 2014; 20: 957–967.
Google Scholar | Crossref | Medline14. Berg, M, Soreide, K. Genetic and epigenetic traits as biomarkers in colorectal cancer. Int J Mol Sci 2011; 12: 9426–9439.
Google Scholar | Crossref | Medline15. Carmona, FJ, Azuara, D, Berenguer-Llergo, A, et al. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev Res 2013; 6: 656–665.
Google Scholar | Crossref16. Schreuders, EH, Grobbee, EJ, Spaander, MC, et al. Advances in fecal tests for colorectal cancer screening. Curr Treat Options Gastroenterol 2016; 14: 152–162.
Google Scholar | Crossref | Medline17. Simon, K . Colorectal cancer development and advances in screening. Clin Interv Aging 2016; 11: 967–976.
Google Scholar | Crossref | Medline | ISI18. Wolf, A, Fontham, E, Church, TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018; 68: 250–281.
Google Scholar | Crossref | Medline19. Winawer, SJ, Fletcher, RH, Miller, L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594–642.
Google Scholar | Crossref | Medline | ISI20. Bond, JH . Colon polyps and cancer. Endoscopy 2005; 37: 208–212.
Google Scholar | Crossref | Medline21. Von Elm, E, Altman, DG, Egger, M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573–577.
Google Scholar | Crossref | Medline | ISI22. Kim, HJ, Yu, MH, Kim, H, et al. Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 2008; 41: 685–692.
Google Scholar | Crossref | Medline23. Wang, YR, Yan, JX, Wang, LN. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer. J Cancer Res Ther 2014; 10(Suppl.): 307–309.
Google Scholar | Crossref | Medline24. Kato, I, Startup, J, Ram, JL. Fecal biomarkers for research on dietary and lifestyle risk factors in colorectal cancer etiology. Curr Colorectal Cancer Rep 2014; 10: 114–131.
Google Scholar | Crossref25. Fujimoto, S, Kitsukawa, U, Itoh, K. Carcinoembryonic antigen (CEA) in gastric juice or feces as an aid in the diagnosis of gastrointestinal cancer. Ann Surg 1979; 189: 34–38.
Google Scholar | Crossref | Medline26. Freed, DL, Taylor, G. Carcinoembryonic antigen in faeces. Br Med J 1972; 1: 85–87.
Google Scholar | Crossref | Medline27. Elias, EG, Holyoke, ED, Chu, TM. Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma. Dis Colon Rectum 1974; 17: 38–41.
Google Scholar | Crossref | Medline28. Kim, M, Kim, H, Lee, IK, et al. Fecal occult blood test/fecal carcinoembriogenic antigen dual rapid test as a useful tool for colorectal cancer screening. Eur Surg 2017; 49: 127–131.
Google Scholar | Crossref29. Thomson, DM, Krupey, J, Freedman, SO, et al. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci USA 1969; 64: 161–167.
Google Scholar | Crossref | Medline | ISI30. Hammarström, S . The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999; 9: 67–81.
Google Scholar | Crossref | Medline | ISI